Sort   by:  
 Page size 
UnknownOnce-Weekly Semaglutide Versus Once-Daily Liraglutide for Weight Loss in Adults: A Meta-Analysis of Randomized Controlled Trials.
Not available
S-EPMC11811509 | biostudies-literature
UnknownSerious Games for Learning Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis.
Not available
S-EPMC10134019 | biostudies-literature
UnknownThe performance of serious games for enhancing attention in cognitively impaired older adults.
Not available
S-EPMC10329640 | biostudies-literature
UnknownOpportunities and challenges to non-communicable disease (NCD) research and training in Pakistan: a qualitative study from Pakistan.
Not available
S-EPMC9764671 | biostudies-literature
UnknownDevelopment and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Not available
S-EPMC5408574 | biostudies-literature
UnknownAntiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
Not available
S-EPMC4481320 | biostudies-literature
UnknownTwelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Not available
S-EPMC4481318 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
Sort   by:  
 Page size